Ethyl travoprostamide
CAS No. 1005193-64-5
MF C25H34F3NO5
Molecular weight 485.54
MF C25H34F3NO5
Molecular weight 485.54
API405
Quantity
Ethyl travoprostamide is a synthetic prostaglandin derivative primarily designed to reduce intraocular pressure (IOP).
It functions by enhancing the outflow of aqueous humor from the eye, a critical mechanism for managing conditions like glaucoma.
1. Mechanism of Action
Ethyl travoprostamide is a synthetic prostaglandin derivative primarily designed to reduce intraocular pressure (IOP).
Ethyl travoprostamide is a synthetic prostaglandin derivative primarily designed to reduce intraocular pressure (IOP).
It functions by enhancing the outflow of aqueous humor from the eye, a critical mechanism for managing conditions like glaucoma.
2. Therapeutic Applications
Glaucoma Treatment: As an anti-glaucoma agent, it is used in ophthalmic formulations to lower elevated IOP, a major risk factor for optic nerve damage .
Cosmetic Use: Ethyl travoprostamide has demonstrated additional effects on eyelash growth,
Cosmetic Use: Ethyl travoprostamide has demonstrated additional effects on eyelash growth,
making it a component in cosmetic products aimed at enhancing lash thickness and length .
3. Research and Development
This compound is primarily utilized in scientific research and pharmaceutical development.
This compound is primarily utilized in scientific research and pharmaceutical development.
Studies focus on optimizing its efficacy, safety profile, and delivery mechanisms for both medical and cosmetic applications.
4. Safety and Regulatory Status
Ethyl travoprostamide-related formulations are subject to rigorous testing to ensure compliance with medical and cosmetic regulatory standards.
Ethyl travoprostamide-related formulations are subject to rigorous testing to ensure compliance with medical and cosmetic regulatory standards.
